These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 11910360

  • 1. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
    Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ.
    Gastroenterology; 2002 Apr; 122(4):1101-12. PubMed ID: 11910360
    [Abstract] [Full Text] [Related]

  • 2. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
    Esquivias P, Morandeira A, Escartín A, Cebrián C, Santander S, Esteva F, García-González MA, Ortego J, Lanas A, Piazuelo E.
    World J Gastroenterol; 2012 Sep 21; 18(35):4866-74. PubMed ID: 23002358
    [Abstract] [Full Text] [Related]

  • 3. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor].
    Zhang T, Su LW, Zhu YF, Lang HJ, Zhang F, Zhou YA, Liang XH, Wang YJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May 21; 15(5):512-6. PubMed ID: 22648851
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 8. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats.
    Oyama K, Fujimura T, Ninomiya I, Miyashita T, Kinami S, Fushida S, Ohta T, Koichi M.
    Carcinogenesis; 2005 Mar 15; 26(3):565-70. PubMed ID: 15564290
    [Abstract] [Full Text] [Related]

  • 9. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
    Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, Lutzke LS.
    J Natl Cancer Inst; 2002 Mar 20; 94(6):422-9. PubMed ID: 11904314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats.
    Kim SW, Jang TJ, Jung KH, Suh JI.
    Yonsei Med J; 2007 Dec 31; 48(6):1020-7. PubMed ID: 18159596
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
    Gupta RA, DuBois RN.
    J Natl Cancer Inst; 2002 Mar 20; 94(6):406-7. PubMed ID: 11904306
    [No Abstract] [Full Text] [Related]

  • 14. [Medical treatment of Barrett's esophagus].
    Kinoshita Y, Yuki T.
    Nihon Rinsho; 2005 Aug 20; 63(8):1449-53. PubMed ID: 16101238
    [Abstract] [Full Text] [Related]

  • 15. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR, Fitzgerald RC.
    Clin Cancer Res; 2004 Jul 15; 10(14):4784-92. PubMed ID: 15269153
    [Abstract] [Full Text] [Related]

  • 16. Unresolved issues in Barrett's esophagus in the new millennium.
    Falk G.
    Dig Dis; 2000 Jul 15; 18(1):27-42. PubMed ID: 10729735
    [No Abstract] [Full Text] [Related]

  • 17. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
    Liu FX, Wang WH, Wang J, Li J, Gao PP.
    Helicobacter; 2011 Feb 15; 16(1):66-77. PubMed ID: 21241415
    [Abstract] [Full Text] [Related]

  • 18. Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Bresalier RS.
    Dig Dis Sci; 2018 Aug 15; 63(8):2155-2162. PubMed ID: 29948566
    [Abstract] [Full Text] [Related]

  • 19. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S.
    Cancer Res; 2001 Aug 15; 61(16):6131-6. PubMed ID: 11507063
    [Abstract] [Full Text] [Related]

  • 20. Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats.
    Nishijima K, Miwa K, Miyashita T, Kinami S, Ninomiya I, Fushida S, Fujimura T, Hattori T.
    Ann Surg; 2004 Jul 15; 240(1):57-67. PubMed ID: 15213619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.